DCPM - Digitalized Clone for Personalized Medicine
The project DCPM - Digitalized Clone for Personalized Medicine (grant agreement No 872488) is a research project supported by the European Union's H2020 Marie Sklodowska-Curie Actions "Research and Innovation Staff Exchange" programme.
The DCPM project aims to enhance the quality and productivity of intensive care by creating validated virtual patient models using model-based methods and novel system identification technologies for metabolic, cardiovascular, and pulmonary systems – the 3 leading causes of intensive care admission, mortality, and cost.
Research Objectives (ROs): The proposed program will create a sustainable Model-based Therapeutics consortium with all required core competencies by focusing on 3 main project areas -- from concept to translated clinical implementation. The sub-projects on these 3 areas are built from existing capabilities to create critical mass by ensuring that capabilities are applied to each sub-project. The inter-disciplinary exchanges to enable this outcome will ensure the general objectives are met. ROs are defined, as follows:
- Development of Glycemic Control for Insulin Insufficient Individuals
- Development of Next-Generation Cardiovascular System Monitoring & Management
- Development of Virtual Patient Model of the Human Lung
The participating EU partners are:
- Budapest University of Technology and Economics (Hungary; BME);
- Hochschule Furtwangen University (Germany; HFU);
- University of Liège (Belgium; ULG);
- Békés County Central Hospital - Pándy Kálmám Member Hospital (Hungary BMKK);
- University of Szeged (Hungary; USZ);
- Evopro Innovation LLC (Hungary; EVO);
- Semmelweis University
- Kiskunhalasi Semmelweis Kórház a Szegedi Tudományegyetem Oktató Kórháza
Third-country participants:
Read more about the scientific and research goals of DCPM in Project Introduction!
Read more about the DCPM results on the official CORDIS web site!
This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 872488.